Stock Events

Stock Events

Search...

Ovid Therapeutics (OVID) Q1 2025 Earnings

11MarConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.22

-0.11

0.01

0.12

Details

Expected EPS

-0.168682

Actual EPS

-0.13

Surprise EPS

0.04

Surprise Percent

+22.93%

Description

Ovid Therapeutics (OVID) has reported earnings of -0.13 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.